NZ776080A - Modified rnai agents - Google Patents
Modified rnai agentsInfo
- Publication number
- NZ776080A NZ776080A NZ776080A NZ77608012A NZ776080A NZ 776080 A NZ776080 A NZ 776080A NZ 776080 A NZ776080 A NZ 776080A NZ 77608012 A NZ77608012 A NZ 77608012A NZ 776080 A NZ776080 A NZ 776080A
- Authority
- NZ
- New Zealand
- Prior art keywords
- dsrna
- rnai agents
- strand
- modified rnai
- agents
- Prior art date
Links
- 108091030071 RNAI Proteins 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000009368 gene silencing by RNA Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed is a double-stranded RNAi (dsRNA) duplex agent capable of inhibiting the expression of a target gene. The dsRNA duplex comprises one or more motifs of three identical modifications on three consecutive nucleotides in one or both strand, particularly at or near the cleavage site of the strand. Other aspects of the invention relates to pharmaceutical compositions comprising these dsRNA agents and the use of such dsRNA agents in the manufacture of a medicament for delivering a polynucleotide to a specific target in a subject.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ797319A NZ797319B2 (en) | 2012-11-16 | Modified RNAi agents |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161561710P | 2011-11-18 | 2011-11-18 | |
NZ75880912 | 2012-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ776080A true NZ776080A (en) | 2023-05-26 |
Family
ID=86613248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ776080A NZ776080A (en) | 2011-11-18 | 2012-11-16 | Modified rnai agents |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ776080A (en) |
-
2012
- 2012-11-16 NZ NZ776080A patent/NZ776080A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018012038A (en) | Modified rnai agents. | |
MX2024005652A (en) | Modified double-stranded rna agents. | |
WO2014022739A3 (en) | Modified rnai agents | |
WO2015106128A3 (en) | Rnai agents modified at the 4'-c-position | |
MX2018013216A (en) | Compositions and methods for inhibiting expression of tmprss6 gene. | |
MX2021006052A (en) | Complement component irna compositions and methods of use thereof. | |
MX2019008380A (en) | Complement component c5 irna compositions and methods of use thereof. | |
MX2021009118A (en) | Compositions and methods for inhibiting expression of the alas1 gene. | |
MX2019009283A (en) | PCSK9 iRNA COMPOSITIONS AND METHODS OF USE THEREOF. | |
MX2011013176A (en) | CHEMICAL MODIFICATION MOTIFS FOR miRNA INHIBITORS AND MIMETICS. | |
MX2019006413A (en) | Serpinc1 irna compositions and methods of use thereof. | |
PE20210921A1 (en) | ARNI AGENTS AS INHIBITORS OF SERPINE 1 TRANSCRIPTION AND COMPOSITIONS THAT INCLUDE THEM | |
MX2011008383A (en) | Synthetic rna-based agonists of tlr7. | |
MX2013005875A (en) | Microrna inhibitors comprising locked nucleotides. | |
MX2022001017A (en) | Compositions and methods for inhibiting expression of the alas1 gene. | |
WO2011139843A3 (en) | Multi-sirna compositions for reducing gene expression | |
NZ776080A (en) | Modified rnai agents | |
MX368084B (en) | Sirna and their use in methods and compositions for the treatment and/or prevention of eye conditions. | |
MY185464A (en) | Complement component c5 irna compositions and methods of use thereof | |
UA96649C2 (en) | Use of glucosamine hydrochloride as frigoprotective agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 9 YEARS UNTIL 16 NOV 2025 BY IPAN GMBH Effective date: 20231012 |